Bulk Manufacturer of Controlled Substances Application: Absolute Standards, Inc., 47522 [2021-18230]
Download as PDF
<![CDATA[
47522
Federal Register / Vol. 86, No. 162 / Wednesday, August 25, 2021 / Notices
comments on or objections to the
issuance of the proposed registration on
or before September 24, 2021. Such
persons may also file a written request
for a hearing on the application on or
before September 24, 2021.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on January 20, 2021,
Cedarburg Pharmaceuticals, 870 Badger
Circle Drive, Grafton, Wisconsin 53024–
9436, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
khammond on DSKJM1Z7X2PROD with NOTICES
Gamma Hydroxybutyric Acid ....
Marihuana Extract .....................
Marihuana .................................
Drug
code
Schedule
2010
7350
7360
I
I
I
I
I
The company plans to import Sodium
Oxybate (derivative of GammaHydroxybutyric Acid) to support
Euticals Inc. post procurement quota
grand. The cannabidiol from Marihuana
and Marihuana Extracts is intended for
analytical purposes with
tetramethylpyrazine. No other activity
for this drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–18233 Filed 8–24–21; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:54 Aug 24, 2021
Jkt 253001
activity for this drug code is authorized
for this registration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–890]
[FR Doc. 2021–18238 Filed 8–24–21; 8:45 am]
Importer of Controlled Substances
Application: Johnson Matthey Inc.
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Brian S. Besser,
Acting Assistant Administrator.
Drug Enforcement Administration
Notice of application.
[Docket No. DEA–860]
Johnson Matthey Inc., has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 24, 2021. Such
persons may also file a written request
for a hearing on the application on or
before September 24, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2021, Johnson
Matthey Inc., 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Nabilone ..........................
I
7379
Schedule
I II
The company plans to import
Nabilone (7379) in order to accept the
return of this controlled substance from
a foreign customer who no longer has a
demand for this substance. No other
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Bulk Manufacturer of Controlled
Substances Application: Absolute
Standards, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Absolute Standards, Inc., has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 25, 2021. Such
persons may also file a written request
for a hearing on the application on or
before October 25, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 31, 2021, Absolute
Standards, Inc., 44 Rossotto Drive,
Hamden, Connecticut 06514–1335,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance:
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Pentobarbital ...................
I
2270
Schedule
III
The company plans to bulk
manufacture the listed controlled
substances for internal use and for sale
to its customers. No other activities for
these drug codes are authorized for this
registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–18230 Filed 8–24–21; 8:45 am]
BILLING CODE P
E:\FR\FM\25AUN1.SGM
25AUN1
]]>Agencies
[Federal Register Volume 86, Number 162 (Wednesday, August 25, 2021)]
[Notices]
[Page 47522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18230]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-860]
Bulk Manufacturer of Controlled Substances Application: Absolute
Standards, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Absolute Standards, Inc., has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before October 25,
2021. Such persons may also file a written request for a hearing on the
application on or before October 25, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 31, 2021, Absolute Standards, Inc., 44 Rossotto
Drive, Hamden, Connecticut 06514-1335, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Pentobarbital........................... 2270 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for internal use and for sale to its customers. No other
activities for these drug codes are authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-18230 Filed 8-24-21; 8:45 am]
BILLING CODE P
